Jonathan Gelfond

7PUBLICATIONS
31CO-AUTHORS
Epidemiological methodsPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsTraditional, complementary and integrative medicine not elsewhere classifiedPsychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 19, 2025
Deciphering the timing and impact of life-extending interventions: temporal efficacy profiler distinguishes early, midlife, and senescence phase efficacies.

Nisi Jiang, Catherine J Cheng, Qianqian Liu

|Jul 28, 2025
Sex as a major determinant of pro-longevity drug efficacy: a review of two decades of the NIA Interventions Testing Program.

Nisi Jiang, Ziying Xu, Shangang Zhao

|Sep 30, 2024
Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI.

Jordan P Hartig, Kaitlyn Bejar, Lyndsay E A Young

|Apr 17, 2024
The Gehan test identifies life-extending compounds overlooked by the log-rank test in the NIA Interventions Testing Program: Metformin, Enalapril, caffeic acid phenethyl ester, green tea extract, and 17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride.

Nisi Jiang, Jonathan Gelfond, Qianqian Liu

|Apr 08, 2024
Deciphering the Timing and Impact of Life-extending Interventions: Temporal Efficacy Profiler Distinguishes Early, Midlife, and Senescence Phase Efficacies.

Nisi Jiang, Catherine J Cheng, Qianqian Liu

|Mar 30, 2022
Prediction of future risk of any and higher-grade prostate cancer based on the PLCO and SELECT trials.

Jonathan A Gelfond, Brian Hernandez, Martin Goros

Pageof 2

Frequent Collaborators

4 joint publications

James F Nelson

4 joint publications

Randy Strong

3 joint publications

Qianqian Liu

3 joint publications

Nisi Jiang